Clariant AG
SIX:CLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Clariant AG
Total Equity
Clariant AG
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Clariant AG
SIX:CLN
|
Total Equity
CHf2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Sika AG
F:SIKA
|
Total Equity
CHf6.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Givaudan SA
SIX:GIVN
|
Total Equity
CHf4.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Total Equity
CHf2.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Total Equity
CHf1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Total Equity
€18.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Clariant AG
Glance View
In the shadow of the Swiss Alps, Clariant AG has carved out its niche as a formidable player in the specialty chemicals landscape. Emerging from the restructuring endeavors of Sandoz in the mid-1990s, Clariant embarked on a journey of metamorphosis, morphing from a collection of diverse chemical assets into a global leader in specialty chemicals. Known for its strategic focus on innovation and sustainability, Clariant divides its operations into critical business areas: Care Chemicals, Catalysis, and Natural Resources. Whether creating advanced emulsifiers for personal care products, catalysts that drive higher yields for petrochemicals, or additives that enhance oil recovery, Clariant continuously adapts to market demands through a commitment to research and development, placing a premium on delivering high-performance and sustainable solutions across industries. Clariant’s business model is deeply tied to innovation-driven solutions that cater to the evolving needs of its clients. The company invests significantly in R&D, with laboratories and research centers spread across strategic global locations, fostering a culture of innovation that synergizes with local markets. Through its intelligent use of its portfolio, Clariant generates revenue by not only meeting the basic needs of its customers but by shaping their expectations toward value-added, environmentally friendly products. This has garnered them a reputation for leadership in sustainability, evidenced by their initiatives aimed at reducing their environmental footprint and facilitating the transition to a low-carbon economy. By focusing on these strategic pillars, Clariant continues to secure its financial position, creating shareholder value while contributing positively to society at large.
See Also
What is Clariant AG's Total Equity?
Total Equity
2B
CHF
Based on the financial report for Dec 31, 2025, Clariant AG's Total Equity amounts to 2B CHF.
What is Clariant AG's Total Equity growth rate?
Total Equity CAGR 5Y
-2%
Over the last year, the Total Equity growth was -13%. The average annual Total Equity growth rates for Clariant AG have been -5% over the past three years , -2% over the past five years .